Insights

Strategic Affiliation Tmunity Therapeutics operates under Kite Pharma, a Gilead company, highlighting a strong strategic backbone and access to established commercialization, distribution, and regulatory capabilities that can accelerate joint business development and market penetration for cell therapy initiatives.

Global Expansion Kite Pharma is expanding manufacturing and facilities across Europe, including the Netherlands, signaling opportunities for supply chain partnerships, regional clinical trial support, and localized manufacturing collaborations to shorten lead times and reduce logistics risk.

Early Line Opportunities Leadership commentary suggests programs exploring earlier lines and even smoldering indications for CAR T therapies, presenting a sales opening for companion diagnostics, biomarker validation services, and clinical data generation support to enable earlier patient access.

Collaborative Ecosystem Recent partnerships and joint efforts with BBG Advanced Therapies and Pregene Biopharma indicate a fertile environment for platform-agnostic service providers (manufacturing tech, analytics, cloud, and integrative IT) to offer scalable solutions tailored to cell therapy workflows.

Technical Enablement Existing tech stack (iCIMS, SAS, AWS, SAP, PostgreSQL, Informatica, Google Cloud, Coupa) suggests a need for specialized data management, analytics, and procurement integration for clinical and manufacturing operations, presenting cross-sell opportunities for data platforms, cloud optimization, and ERP/SCM enhancements.

Similar companies to Tmunity Therapeutics Incorporated

Tmunity Therapeutics Incorporated Tech Stack

Tmunity Therapeutics Incorporated uses 8 technology products and services including iCIMS, SAS, Amazon Web Services, and more. Explore Tmunity Therapeutics Incorporated's tech stack below.

Media & News

Tmunity Therapeutics Incorporated's Email Address Formats

Tmunity Therapeutics Incorporated uses at least 6 email formats:
Tmunity Therapeutics Incorporated Email FormatsExamplePercentage
First.Last@tmunity.comJohn.Doe@tmunity.com
96%
Last@tmunity.comDoe@tmunity.com
4%
FLast@kitepharma.comJDoe@kitepharma.com
83%
First.Last@kitepharma.comJohn.Doe@kitepharma.com
14%
FMiddleLast@kitepharma.comJMichaelDoe@kitepharma.com
2%
LastFir@kitepharma.comDoeJoh@kitepharma.com
1%

Frequently Asked Questions

What is Tmunity Therapeutics Incorporated's phone number?

Minus sign iconPlus sign icon
You can contact Tmunity Therapeutics Incorporated's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Tmunity Therapeutics Incorporated's official website and social media links?

Minus sign iconPlus sign icon
Tmunity Therapeutics Incorporated's official website is kitepharma.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Tmunity Therapeutics Incorporated generate?

Minus sign iconPlus sign icon
As of August 2026, Tmunity Therapeutics Incorporated's annual revenue is estimated to be $1M - $10M.

What is Tmunity Therapeutics Incorporated's SIC code and NAICS code?

Minus sign iconPlus sign icon
Tmunity Therapeutics Incorporated's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Tmunity Therapeutics Incorporated have currently?

Minus sign iconPlus sign icon
As of August 2026, Tmunity Therapeutics Incorporated has approximately 5 employees across 3 continents, including North America, Asia and Europe. Key team members include Vice President, Process Development: T. B., Executive Director Human Resources: L. G. and Senior Director Clinical Operations: P. H. Explore Tmunity Therapeutics Incorporated's employee directory with LeadIQ.

What industry does Tmunity Therapeutics Incorporated belong to?

Minus sign iconPlus sign icon
Tmunity Therapeutics Incorporated operates in the Biotechnology Research industry.

What technology does Tmunity Therapeutics Incorporated use?

Minus sign iconPlus sign icon
Tmunity Therapeutics Incorporated's tech stack includes iCIMS, SAS, Amazon Web Services, SAP, PostgreSQL, Informatica, Google Cloud and Coupa.

What is Tmunity Therapeutics Incorporated's email format?

Minus sign iconPlus sign icon
Tmunity Therapeutics Incorporated's email format typically follows the pattern of First.Last@tmunity.com. Find more Tmunity Therapeutics Incorporated email formats with LeadIQ.

How much funding has Tmunity Therapeutics Incorporated raised to date?

Minus sign iconPlus sign icon
As of August 2026, Tmunity Therapeutics Incorporated has raised $230M in funding. The last funding round occurred on Oct 31, 2019 for $75M.

When was Tmunity Therapeutics Incorporated founded?

Minus sign iconPlus sign icon
Tmunity Therapeutics Incorporated was founded in 2009.
Tmunity Therapeutics Incorporated logo

Tmunity Therapeutics Incorporated

Biotechnology ResearchPennsylvania, United States2-10 Employees

Tmunity Therapeutics Incorporated operates within the biotechnology research sector and is part of Kite, a Gilead company focused on cell therapy for cancer. While the organization’s LinkedIn page notes that comments are not actively monitored, the broader context identifies Tmunity as a contributor to Kite’s emphasis on developing cell-based treatments, aligning with Kite’s role as a global leader in this field. Based in Philadelphia, Pennsylvania, the company is associated with a quickly evolving landscape of cell therapy research and development, including collaborations and expansions that reflect ongoing activity in the category. The current information situates Tmunity as a small, research-oriented entity within a larger corporate structure pursuing next-generation cellular therapies for cancer. A recent development noted in industry coverage highlights Kite Pharma’s active collaboration efforts and continued progress in advanced cell therapy programs, which indirectly involve Tmunity through the corporate relationship.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
2-10

Section iconFunding & Financials

  • $230M

    Tmunity Therapeutics Incorporated has raised a total of $230M of funding over 5 rounds. Their latest funding round was raised on Oct 31, 2019 in the amount of $75M as a Series B.

  • $1M - $10M

    Tmunity Therapeutics Incorporated's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.